The Turkish Competition Authority, Rekabet Kurumu, has initiated a formal investigation into Teva İlaçları San. ve Tic. AŞ, Teva Pharmaceuticals Europe B.V., and Teva Pharmaceutical Industries Ltd. to determine whether the companies infringed Article 6 of the Turkish Competition Law by engaging in practices that may have restricted competition from generic medicines.














